A detailed history of Banque Transatlantique Sa transactions in Merck & Co., Inc. stock. As of the latest transaction made, Banque Transatlantique Sa holds 23,403 shares of MRK stock, worth $2.17 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
23,403
Previous 23,433 0.13%
Holding current value
$2.17 Million
Previous $1.85 Million 5.93%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$77.6 - $87.37 $2,328 - $2,621
-30 Reduced 0.13%
23,403 $1.96 Million
Q2 2025

Aug 14, 2025

SELL
$73.47 - $87.12 $30.8 Million - $36.5 Million
-418,552 Reduced 94.7%
23,433 $1.85 Million
Q1 2025

Sep 09, 2025

BUY
$83.01 - $101.02 $16,602 - $20,204
200 Added 0.85%
23,633 $2.12 Billion
Q1 2025

May 15, 2025

BUY
$83.01 - $101.02 $34.6 Million - $42.1 Million
416,674 Added 1646.22%
441,985 $39.7 Million
Q4 2024

Feb 14, 2025

BUY
$96.31 - $114.76 $2.44 Million - $2.9 Million
25,311 New
25,311 $2.51 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Banque Transatlantique Sa Portfolio

Follow Banque Transatlantique Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Transatlantique Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Transatlantique Sa with notifications on news.